NBP
NovaBridge Biosciences
1.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +439.7% | +0.0% | -29.4% | -11.5% | -87.0% | -1.8% | -1.1% | +6,702.7% | -98.1% | -10.9% | -0.2% | |
| – | +451.2% | +0.0% | -28.3% | -21.1% | -86.6% | -2.0% | -3.2% | +6,938.4% | -98.2% | -8.8% | -0.2% | |
| – | +558.3% | +5.1% | -50.9% | -49.6% | -87.7% | -21.5% | +208.6% | +6,889.2% | -98.2% | -9.3% | -0.2% | |
| – | +463.8% | -1.7% | -33.0% | -14.2% | – | – | -1.8% | +6,886.8% | – | – | -0.2% | |
| – | – | – | – | – | – | – | -56.1% | +225.4% | – | – | +2,100.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +623.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +509.5% | -295.7% | – | -16.9% | -88.9% | -8.0% | -5.9% | +9,298.5% | -96.8% | +3.1% | -0.2% | |
| – | +350.5% | +0.0% | -75.3% | -18.6% | -89.8% | -8.3% | -5.2% | +11,002.3% | -96.7% | -3.4% | -0.2% | |
| – | +556.6% | +0.0% | -89.7% | -1.3% | – | – | +2.2% | +5,081.8% | – | – | -0.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -0.2% | |
| – | +409.4% | +1.9% | -1.8% | -11.1% | -86.8% | -1.4% | -0.8% | +6,571.1% | -98.2% | -12.7% | -0.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | -2.9% | +0.1% | +0.7% | +130.0% | -56.5% | +0.1% | -46.3% | +504.6% | -56.4% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.